eMOMS of Rochester (eMOMS)

November 30, 2015 updated by: Diana Fernandez, University of Rochester

Electronically-Mediated Weight Interventions for Pregnant and Postpartum Women

The project aims to develop, implement and evaluate electronically-mediated behavioral intervention programs for pregnant and postpartum women in order to prevent excessive weight gain during pregnancy and postpartum weight retention.

Study Overview

Detailed Description

This study seeks to expand the understanding of how to slow the accumulation of weight in childbearing women. The intervention goals are to decrease the prevalence of excessive pregnancy weight gain and mean weight retention in the first 18 months postpartum in socio-economically and racially/ethnically diverse sample of 1,641 pregnant women. Women will be randomly assigned to one of three groups: Intervention Group 1 will receive the intervention program only during pregnancy (e-intervention 1). Intervention Group 2 will receive e-intervention 1 plus intervention for 18 months postpartum (e-intervention 2). Control women will receive non-weight related content during both time periods at the project website. The primary hypotheses for the randomized controlled trial are: H1: The proportion of women in Intervention Groups 1 and 2 who gain more weight in pregnancy than is recommended by the IOM will be 33% less than the proportion of the women in the Control Group who gain excessively and H2: The Control Group will have a higher mean weight retention at 12 months postpartum than Intervention Groups 1 and 2.

Study Type

Interventional

Enrollment (Actual)

1641

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • Rochester, New York, United States, 14642
        • University of Rochester

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Age 18 - 35 at the time of delivery
  • Consented at or before 20 weeks gestation
  • Intending to be available for a 24 months intervention
  • Plan to deliver in one of the 4 hospitals in Rochester, NY (the study area)
  • Plan to carry the pregnancy to term
  • Plan to keep the baby
  • Read and understand English

Exclusion Criteria:

  • BMI < 18.5 kg/m2 and > 35.0 kg/m2.
  • Multiple gestation. If multiple gestation is diagnosed after enrollment participant will be terminated from the study (reasons for termination will be included in the consent form)
  • Medical conditions prior to pregnancy which could influence weight loss or gain: cystic fibrosis, hyperthyroidism, renal insufficiency1, proteinuria1, cerebral palsy, lupus erythematosus; rheumatoid arthritis, Crohns disease (severity and other autoimmune diseases evaluated case by case), ulcerative colitis, maternal congenital heart disease (patients are often underweight); hypertension treated with medication2,
  • Psychiatric medication associated with major weight gain or loss (e.g.; Lithium & Divalproex) Common Criteria
  • Household member on study staff
  • Past or planned (within the next 24 months) weight loss surgery (e.g. gastric bypass, lap band, or liposuction); current participation in a commercial weight loss program (e.g. Weight Watcher's, Jenny Craig); currently enrolled or planned to enroll in a weight loss or another weight gain prevention study
  • Participants will be excluded during screening if they report regular use of systemic steroids, prescription weight loss drugs, and/or diabetes medications (oral or injected- insulin, metformin, byetta, TZDs, other). "Regular use" is defined as "taking this medication most days of the week for the previous month"
  • Current treatment for eating disorder
  • Positive screening for bulimia
  • Weight loss of more than 15 pounds in the three months prior to pregnancy
  • Cardiovascular event (heart attack, stroke, episode of heart failure, or revascularization procedure) within the last 6 month. Revascularization is defined as bypass surgery or stints
  • Mental or psychiatric condition that precludes giving informed consent and completing questionnaires
  • Current treatment for malignancy (other than non-melanoma skin cancer and CIN cervix) or on remission for less than 5 years
  • Blood pressure criterion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Control
Control women will receive non-weight related content during both time periods at the project website.
Other Names:
  • Control group
Experimental: electronic intervention group 2
(e-intervention 2) receives a behavioral intervention through a website during pregnancy and until 18 months postpartum
Electronically-mediated behavioral interventions to encourage women to gain an appropriate amount of weight during pregnancy and to follow a healthy lifestyle postpartum to minimize postpartum weight retention
Other Names:
  • Behavior modification intervention for pregnancy
  • Behavior modification intervention for postpartum
  • Prevention of excessive gestational weight gain
  • Prevention of postpartum weight retention
  • Electronically-mediated behavioral interventions
Experimental: electronic intervention group 1
(e-intervention 1) receives a behavioral intervention through a website during pregnancy. During the postpartum period this arm receives the same non-weight-related information as the control arm
Electronically-mediated behavioral interventions to encourage women to gain an appropriate amount of weight during pregnancy.
Other Names:
  • Behavior modification intervention for pregnancy
  • Prevention of excessive gestational weight gain
  • Electronically-mediated behavioral interventions

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of women whose gestational gain is within the recommended gestational weight gain Institute of Medicine Guidelines in kilograms
Time Frame: 40 weeks
Gestational weight gain is the result of the last predelivery weight minus the prepregnancy weight (or early pregnancy weight).
40 weeks
Postpartum weight retention in kg at 12 months postpartum
Time Frame: 1.5 years
The difference between the weight at 12 months postpartum and the pre-pregnancy weight (or early pregnancy weight. Participants will be followed for a maximum of 2 years from recruitment in early pregnancy to 18 months postpartum. The final outcome in the postpartum period is postpartum weight retention at 18 months. Interim measure of postpartum weight will be collected at 6 and 12 months for analyses. The primary hypothesis for the postpartum period is weight retention at 12 months postpartum.
1.5 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Caloric Intake in Kilocalories
Time Frame: 2 years
Caloric intake will be calculated based on the average food intake assessed by 2 24-hour dietary recall.
2 years
Physical activity as an average weekly energy expenditure (METS)
Time Frame: 2 years
Physical activity during pregnancy is measured using the Pregnancy Physical Activity Questionnaire and during postpartum using the Global Physical Activity Questionnaire.
2 years
Postpartum weight retention at 18 months
Time Frame: 2 years
The difference between the weight at 18 months postpartum and the prepregnancy weight (or early pregnancy weight). Participants will be followed for a maximum of 2 years from recruitment in early pregnancy to 18 months postpartum. The final outcome in the postpartum period is postpartum weight retention at 18 months. Interim measure of postpartum weight will be collected at 6 and 12 months for analyses. The primary hypothesis for the postpartum period is weight retention at 12 months postpartum
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Isabel D Fernandez, MD, MPH, PhD, University of Rochester
  • Principal Investigator: Christine M Olson, PhD, Cornell University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2011

Primary Completion (Actual)

May 1, 2014

Study Completion (Actual)

December 1, 2014

Study Registration Dates

First Submitted

March 31, 2011

First Submitted That Met QC Criteria

April 6, 2011

First Posted (Estimate)

April 8, 2011

Study Record Updates

Last Update Posted (Estimate)

December 2, 2015

Last Update Submitted That Met QC Criteria

November 30, 2015

Last Verified

November 1, 2015

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Gestational Weight Gain

Clinical Trials on electronic intervention during pregnancy and postpartum

Subscribe